Yahoo Web Search

Search results

  1. May 4, 2017 · Celso Guedes de Carvalho, CEO of Portugal Ventures, one of Alfama’s largest shareholders, added, “This transaction demonstrates how supporting investments for the ‘long-haul’ – given the capital and time required in the biotech sector – allows breakthrough technologies to reach patients.

  2. May 7, 2017 · The Proterris-Alfama proposition for CO therapy received around $23m in funding for three Phase II clinical trials using low-dose CO gas. The US National Institutes of Health (NIH) has funded these trials for the last five years for indications covered by patents licensed from a group of top US universities or written by Proterris.

  3. Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most. Information on acquisition, funding, cap tables, investors, and executives for Alfama. Use the PitchBook Platform to explore the full profile.

    • 15
  4. Alfama is a pharmaceutical company that develops Carbon Monoxide-Releasing Molecules (CORMs) for therapy. The company has produced hundreds of CORMs and obtained exceptional results in various animal models of chronic and acute human diseases. CORMs have the potential to expand CO-based therapy to a wide range of high-value indications, can be.

    • Boston, Massachusetts
  5. www.bioalabama.comBioAlabama

    BIO Alabama is the leading advocate for Alabama's bioeconomy. We represent the state on a national and international stage, promoting the intellectual and innovative capital that make our state a premier place to invest, start, and grow in bioscience. #BioAlabama: Driving the #biotech industry forward.

  6. ALFAMA is a young pharmaceutical company dedicated to the development of small-molecule drugs for unmet medical needs. ALFAMA's carbon monoxide releasing molecules (CORMs) hold the promise of contributing decisively to the prevention and cure of diseases involving inflammatory, infectious, thrombotic and apoptotic processes.

  7. People also ask

  8. Headquarters Regions Greater Boston Area, East Coast, New England. Founded Date 2005. Founders Jeffrey D. Wager, Joseph Wager. Operating Status Active. Last Funding Type Venture - Series Unknown. Legal Name Proterris, Inc. Company Type For Profit. Contact Email info@proterris.com. Proterris, a P2 clinical-stage firm, has pooled a dominant IP ...

  1. People also search for